SOBEL BURTON E

CIK 00011968555 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001196855

Recent Transactions

42 trades

Award
ARIAD PHARMACEUTICALS INC
Restricted Stock Units
2008-01-18+10,000→ 10,000 total
Award
ARIAD PHARMACEUTICALS INC
Restricted Stock Units
2008-01-18+10,000→ 10,000 total
Exercise/Conversion
ARIAD PHARMACEUTICALS INC
Restricted Stock Units
2008-01-17+10,000→ 0 total
Exercise/Conversion
ARIAD PHARMACEUTICALS INC
Common Stock
2008-01-17+10,000→ 10,000 total
Exercise/Conversion
ARIAD PHARMACEUTICALS INC
Common Stock
2008-01-17+10,000→ 10,000 total
Exercise/Conversion
ARIAD PHARMACEUTICALS INC
Restricted Stock Units
2008-01-17+10,000→ 0 total
Sale
NEW RIVER PHARMACEUTICALS INC
Common Stock
2007-01-03$54.83/sh−2,500→ 0 total
Exercise/Conversion
NEW RIVER PHARMACEUTICALS INC
Stock Option (right to buy)
2007-01-03−2,500→ 0 total
Sale
NEW RIVER PHARMACEUTICALS INC
Common Stock
2007-01-03$54.83/sh−2,500→ 0 total
Exercise/Conversion
NEW RIVER PHARMACEUTICALS INC
Common Stock
2007-01-03$11.60/sh+2,500→ 2,500 total
Exercise/Conversion
NEW RIVER PHARMACEUTICALS INC
Stock Option (right to buy)
2007-01-03−2,500→ 0 total
Exercise/Conversion
NEW RIVER PHARMACEUTICALS INC
Common Stock
2007-01-03$11.60/sh+2,500→ 2,500 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-11-10$6.50/sh+12,500→ 12,500 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-11-10$18.17/sh−12,500→ 0 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2006-11-10−12,500→ 0 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-08-10$6.50/sh+12,500→ 12,500 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-08-10$16.00/sh−12,500→ 0 total
Award
ARIAD PHARMACEUTICALS INC
Stock Option (Right to Buy)
2006-06-14+20,000→ 20,000 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-05-26$15.59/sh−7,500→ 0 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-05-26$15.59/sh−1,100→ 0 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-05-25$9.67/sh+3,900→ 3,900 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-05-25$6.72/sh+7,500→ 7,500 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-05-25$9.67/sh+1,100→ 1,100 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2006-05-25$15.58/sh−3,900→ 0 total
Award
ARIAD PHARMACEUTICALS INC
Restricted Stock Units
2006-01-17+10,000→ 0 total
Sale
ARIAD PHARMACEUTICALS INC
Common Stock
2006-01-09$6.50/sh−5,853→ 4,147 total
Sale
ARIAD PHARMACEUTICALS INC
Common Stock
2006-01-09$6.50/sh−5,853→ 4,147 total
Exercise/Conversion
NEW RIVER PHARMACEUTICALS INC
Common Stock
2005-08-19$8.00/sh+5,000→ 5,000 total
Sale
NEW RIVER PHARMACEUTICALS INC
Common Stock
2005-08-19$36.95/sh−5,000→ 0 total
Exercise/Conversion
NEW RIVER PHARMACEUTICALS INC
Stock Option (right to buy)
2005-08-19−5,000→ 0 total
Sale
NEW RIVER PHARMACEUTICALS INC
Common Stock
2005-08-19$36.95/sh−5,000→ 0 total
Exercise/Conversion
NEW RIVER PHARMACEUTICALS INC
Stock Option (right to buy)
2005-08-19−5,000→ 0 total
Exercise/Conversion
NEW RIVER PHARMACEUTICALS INC
Common Stock
2005-08-19$8.00/sh+5,000→ 5,000 total
Award
Oruka Therapeutics, Inc.$ORKA
Non-Qualified Stock Option (right to buy)
2005-05-24+15,000→ 15,000 total
Sale
ARIAD PHARMACEUTICALS INC
Common Stock
2004-09-20$6.13/sh−10,000→ 0 total
Sale
ARIAD PHARMACEUTICALS INC
Common Stock
2004-09-20$6.13/sh−10,000→ 0 total
Award
NEW RIVER PHARMACEUTICALS INC
Stock Option (right to buy)
2004-08-10+5,000→ 5,000 total
Award
NEW RIVER PHARMACEUTICALS INC
Stock Option (right to buy)
2004-08-10+5,000→ 5,000 total
Award
ARIAD PHARMACEUTICALS INC
Common Stock
2004-01-15+10,000→ 10,000 total
Award
ARIAD PHARMACEUTICALS INC
Common Stock
2004-01-15+10,000→ 10,000 total
Purchase
DENDREON CORP
dendreon stock
2003-08-26$2.98/sh+3,600→ 3,600 total
Purchase
DENDREON CORP
dendreon stock
2003-08-26$2.98/sh+3,600→ 3,600 total

Companies

Recent Filings

Address

C/O ARIAD PHARMACEUTICALS, INC 21 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov